Keywords: merck, co, 3rd-qtr, sales, jump, drug, major
Merck & Co's 3rd-qtr 2007 sales jump 12%
Article | 29 October 2007
US drug major Merck & Co's third-quarter 2007 earnings per share totaled $0.75, excluding restructuring charges, and $0.70 per share otherwise versus $0.43 per share ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
